Loading...
•
Mar 31, 2023
Multiplan Q1 2023 Earnings Report
Reported first quarter results with revenues of $236.6 million and net income of $0.2 million.
Key Takeaways
MultiPlan Corporation reported a decrease in revenues, net income, and Adjusted EBITDA for Q1 2023 compared to Q1 2022, but saw a 3% increase in potential medical cost savings compared to Q4 2022. The company is focused on executing its Growth Plan and launching new products, expecting to accelerate growth in 2024 and beyond.
Revenues for Q1 2023 were $236.6 million, a decrease of 20.6% compared to Q1 2022.
Net income for Q1 2023 was $0.2 million, a decrease of 99.5% compared to Q1 2022.
Adjusted EBITDA for Q1 2023 was $156.3 million, a decrease of 30.7% compared to Q1 2022.
Identified potential medical cost savings of approximately $5.6 billion in Q1 2023, up 3% from Q4 2022.
Forward Guidance
The Company is reaffirming its Full Year 2023 guidance.
Positive Outlook
- Revenues: $925 million to $975 million
- Adjusted EBITDA: $600 million to $650 million
- Cash flow from operations: $175 million to $215 million
- The Company anticipates Q2 2023 revenues between $220 million and $235 million
- The Company anticipates Q2 2023 Adjusted EBITDA between $140 million and $155 million
Challenges Ahead
- Interest expense: $325 million to $340 million
- Capital expenditures: $100 million to $115 million
- Depreciation: $70 million to $75 million
- Amortization of intangible assets: $335 million to $345 million
- Effective tax rate 25% to 28%
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...